| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11892-018-1010-8 |
| P698 | PubMed publication ID | 29884917 |
| P2093 | author name string | Jiao Wu | |
| Natasha Dave | |||
| Sandhya Thomas | |||
| P2860 | cites work | Inflammation and insulin resistance | Q22241893 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
| SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 | Q28201656 | ||
| MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling | Q28589862 | ||
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
| Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. | Q33559582 | ||
| Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group compar | Q33612741 | ||
| Changes in metformin use in chronic kidney disease | Q33783138 | ||
| Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance | Q35159345 | ||
| Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients | Q35163405 | ||
| Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes | Q36050559 | ||
| Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study | Q36217890 | ||
| Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review | Q36240156 | ||
| p-Cresyl sulfate promotes insulin resistance associated with CKD | Q36509307 | ||
| Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes | Q36560528 | ||
| Pioglitazone after Ischemic Stroke or Transient Ischemic Attack | Q36953272 | ||
| Insulin resistance in uremia | Q36995902 | ||
| Measurement of insulin resistance in chronic kidney disease | Q37017696 | ||
| IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting | Q37123224 | ||
| Bicarbonate supplementation slows progression of CKD and improves nutritional status | Q37330555 | ||
| Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect | Q37352094 | ||
| The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway | Q37353181 | ||
| Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients | Q37524302 | ||
| c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action | Q37591960 | ||
| Myostatin induces insulin resistance via Casitas B-lineage lymphoma b (Cblb)-mediated degradation of insulin receptor substrate 1 (IRS1) protein in response to high calorie diet intake | Q37635807 | ||
| Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus | Q38380127 | ||
| Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes | Q38729780 | ||
| Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease | Q39177982 | ||
| Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting | Q40891663 | ||
| Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial | Q41085122 | ||
| Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. | Q41895967 | ||
| Low pH accelerates dissociation of receptor-bound insulin | Q41921162 | ||
| Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. | Q42825786 | ||
| Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes | Q42826146 | ||
| Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. | Q43072840 | ||
| Molecular mechanisms of insulin resistance in chronic kidney disease | Q43135175 | ||
| Relationship between insulin resistance and inflamation markers in hemodialysis patients | Q43144145 | ||
| Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. | Q43195092 | ||
| Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle | Q43258663 | ||
| A model-based method for assessing insulin sensitivity from the oral glucose tolerance test | Q43566553 | ||
| Tumor necrosis factor-alpha modulates human in vivo lipolysis | Q43590617 | ||
| Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease | Q44044865 | ||
| Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study | Q44280677 | ||
| Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats | Q44623524 | ||
| Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients | Q45032343 | ||
| Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance | Q46966521 | ||
| Correcting Postprandial Hyperglycemia in Zucker Diabetic Fatty Rats With an SGLT2 Inhibitor Restores Glucose Effectiveness in the Liver and Reduces Insulin Resistance in Skeletal Muscle. | Q51118064 | ||
| Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. | Q51327721 | ||
| Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. | Q51557396 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. | Q51577363 | ||
| Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. | Q52077110 | ||
| Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. | Q53084508 | ||
| Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | Q57491397 | ||
| Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- are similarly associated with survival in haemodialysis patients | Q59361696 | ||
| Insulin Resistance, Inflammatory Biomarkers, and Adipokines in Patients with Chronic Kidney Disease: Effects of Angiotensin II Blockade | Q61188039 | ||
| Insulin Resistance Is Associated With Circulating Fibrinogen Levels in Nondiabetic Patients Receiving Peritoneal Dialysis | Q61927953 | ||
| Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease | Q62775739 | ||
| Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1 | Q71743266 | ||
| A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients | Q73293460 | ||
| Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels | Q74487536 | ||
| Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state | Q77900275 | ||
| Relationship of insulin resistance in chronic haemodialysis patients with inflammatory indicators, malnutrition, echocardiographic parameters and 24 hour ambulatory blood pressure monitoring | Q84023988 | ||
| P433 | issue | 7 | |
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 44 | |
| P577 | publication date | 2018-06-08 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field | |
| P478 | volume | 18 |
| Q60948577 | Theaflavins Improve Insulin Sensitivity through Regulating Mitochondrial Biosynthesis in Palmitic Acid-Induced HepG2 Cells | cites work | P2860 |
Search more.